abstract |
The invention concerns novel conjugates of peptides having 3-12 amino acids, residues, and lipophilic moieties, which may be present at the N- or C- terminal of the peptides. The invention further concerns pharmaceutical compositions comprising said novel conjugates which may be used for the treatment of male impotence or for the treatment of neurodegenerative diseases. |